FDA approved Paxlovid for mild COVID-19 patients

来源: 于 2023-01-19 14:11:41 [旧帖] [给我悄悄话] 本文已被阅读：次

US FDA approved Paxlovid for mild COVID-19 patients within 5 days. This drug has significant interactiion with many drugs. Severe case are treated with Remdesivir with other medication and oxygen.